Mefloquine Hydrochloride
- Product NDC
- 62135-973
- 11-digit product format
- 621350973
- Labeler code
- 62135
- Product ID
- 62135-973_2732839a-191a-570f-e063-6294a90a40a4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mefloquine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA076175
- Marketing category
- ANDA
- Marketing start
- 2022-02-20
- Substance
- MEFLOQUINE HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Antimalarial [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mefloquine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MEFLOQUINE HYDROCHLORIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5Y9L3636O3 |
| Rxcui | 835913 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-973-11 | Mefloquine Hydrochloride | 5 in 1 BOTTLE | TABLET | 5 | | 1 |
| 62135-973-25 | Mefloquine Hydrochloride | 25 in 1 BOTTLE | TABLET | 25 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-973 | MEFLOQUINE HYDROCHLORIDE TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 2 package rows | 20241120_b884d22b-aae7-4f14-9a04-ae4029a229f0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-973-11 | 62135097311 | 5 TABLET in 1 BOTTLE (62135-973-11) | 5 tablet | 2024-11-15 | No | No | Historical |
| 62135-973-25 | 62135097325 | 25 TABLET in 1 BOTTLE (62135-973-25) | 25 tablet | 2024-11-15 | No | No | Historical |